Anti-inflammatory effect of theophylline in rats and its involvement of the glucocorticoid-glucocorticoid receptor system

Journal of Pharmacological Sciences

Volumn 106, Issue 4, 2008, Pages 566-570

  Watanabe, Shigekazu ^a,b   Yamakami, Jun ^a,d   Tsuchiya, Masao ^a,d   Terajima, Tomoko ^a   Kizu, Junko ^a   Hori, Seiji ^c  

^a KEIO UNIVERSITY   (Japan)

^b International University of Health and Welfare Mita Hospital   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TEIKYO UNIVERSITY   (Japan)

Author keywords

Anti inflammation; Carrageenan; Glucocorticoid; Theophylline

Indexed keywords

1 METHYLURIC ACID; 1 METHYLXANTHINE; 1,3 DIMETHYLURIC ACID; 3 METHYLXANTHINE; AMINOGLUTETHIMIDE; CARRAGEENAN; DRUG METABOLITE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; MIFEPRISTONE; THEOPHYLLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EDEMA; FOOT PAD; MALE; NONHUMAN; RAT;

EID: 42349113628     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0071816     Document Type: Article

References (11)

1. Ohta K, Sawamoto S, Nakajima M, Kubota S, Tanaka Y, Miyasaka T, et al. The prolonged survival of human eosinophils with interleukin-5 and its inhibition by theophylline via apoptosis. Clin Exp Allergy. 1996;26:10-15.
2. Tohda Y, Nakahara H, Kubo H, Muraki M, Fukuoka M, Nakajima S. Theophylline suppresses the release of interleukin-4 by peripheral blood mononuclear cells. Int Arch Allergy Immunol. 1998;115:42-46.
3. Nassif EG, Weinberger M, Thompson R, Huntley W. The value of maintenance theophylline in steroid-dependent asthma. N Engl J Med. 1981;304:71-75.
4. Pauwels R, Van Renterghem D, Van Der Straeten M, Johannesson N, Persson C. The effect of theophylline and enprofylline on allergen-induced bronchoconstriction. J Allergy Clin Immunol. 1985;76:583-590.
5. Sullivan P, Bekir S, Jaffar Z, Page C, Jeffery P, Costello J. Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. Lancet. 1994;343:1006-1008.
6. Page CP. Recent advances in our understanding of the use of theophylline in treatment of asthma. J Clin Pharmacol. 1999;39:237-240.
7. Chabner BA, Ryan DP, Paz-Ares L, Garcia-Carbonero R, Calabresi P. Antineoplastic agents. In: Hardman JG, Limbird LE, editors. Goodman & Gilman's The pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill; 2001. p. 1389-1459.
8. Loose-Mitchell DS, Stancel GM. Estrogens and progestins. In: Hardman JG, Limbird LE, editors. Goodman & Gilman's The pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill; 2001. p. 1597-1634.
9. Abdel-Salam OM, Baiuomy AR, El-Shenawy SM, Arbid MS. The anti-inflammatory effects of the phosphodiesterase inhibitor pentoxifylline in the rat. Pharmacol Res. 2003;47:331-340.
10. Sato J, Hori S, Kawamura M. Effect of theophylline, caffeine and dimethylxanthines on endogenous glucocorticoid levels in mice. A possible mechanism of anti-inflammatory activity of theophylline. Pharm Pharmacol Commun. 1998;4:499-501.
11. Williams JF, Lowitt S, Polson JB, Szentivanyi A. Pharmacological and biochemical activities of some monomethylxanthine and methyluric acid derivatives of theophylline and caffeine. Biochem Pharmacol. 1978;27:1545-1550.